Hub Tobias, Cornean Alex, Round Kellen, Fleming Thomas, Freichel Marc, Medert Rebekka
Institute of Pharmacology, Heidelberg University, Heidelberg 69120, Germany.
Partner Site Heidelberg/Mannheim, DZHK (German Centre for Cardiovascular Research), Heidelberg, Germany.
ACS Pharmacol Transl Sci. 2024 May 2;7(5):1291-1301. doi: 10.1021/acsptsci.3c00338. eCollection 2024 May 10.
Clonal cell lines harboring loss-of-function mutations in genes of interest are crucial for studying the cellular functions of the encoded proteins. Recent advances in genome engineering have converged on the CRISPR/Cas9 technology to quickly and reliably generate frameshift mutations in the target genes across various cell lines and species. Although high on-target cleavage efficiencies can be obtained reproducibly, screening and identifying clones with loss-of-function alleles remains a major bottleneck. Here, we describe a single sgRNA strategy to generate CRISPR/Cas9-mediated frameshift mutations in target genes of mammalian cell lines that can be easily and cost-effectively identified. Given the proliferation of workhorse cell lines such as N2a cells and the resulting clonal expansion of the cell type, our protocol can facilitate the isolation of knockout clonal cell lines and their genetic validation within a period of down to 6-8 weeks.
携带感兴趣基因功能丧失突变的克隆细胞系对于研究编码蛋白的细胞功能至关重要。基因组工程的最新进展集中在CRISPR/Cas9技术上,以便在各种细胞系和物种的靶基因中快速可靠地产生移码突变。尽管可以可重复地获得高靶向切割效率,但筛选和鉴定具有功能丧失等位基因的克隆仍然是一个主要瓶颈。在此,我们描述了一种单sgRNA策略,用于在哺乳动物细胞系的靶基因中产生CRISPR/Cas9介导的移码突变,这些突变可以轻松且经济高效地鉴定。鉴于诸如N2a细胞等常用细胞系的增殖以及由此导致的细胞类型的克隆扩增,我们的方案可以在低至6 - 8周的时间内促进敲除克隆细胞系的分离及其基因验证。